Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy

INTRODUCTION: Locoregional interventional therapy including transcatheter arterial chemoembolization (TACE) and ablation are the current standard of treatment for early-to-mid-stage hepatocellular carcinoma (HCC). However, questions remain unanswered regarding the management of recurrence after loco...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Wenying, Wang, Qi, Hu, Caixia, Zhang, Yinghua, Li, Jianjun, Sun, Yu, Yuan, Chunwang, Wang, Wen, Liu, Biyu, Zhang, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650042/
https://www.ncbi.nlm.nih.gov/pubmed/36389724
http://dx.doi.org/10.3389/fimmu.2022.1019772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650042/
https://www.ncbi.nlm.nih.gov/pubmed/36389724
http://dx.doi.org/10.3389/fimmu.2022.1019772

Ejemplares similares